90 adult HD patients already suffering from ESRD, were enrolled and randomly assigned to 4 different groups, 2 of which comprised of IV EPO therapy and the other 2 SC EPO therapy. The study involved 4 different phases of treatment. Here, EPO is linked to Huntington disease.